Skip to main content
. 2026 Jul 31;14(8):1736. doi: 10.3390/biomedicines14081736
4Kscore four-kallikrein panel blood test (proprietary name)
ADC apparent diffusion coefficient
AI artificial intelligence
AUA American Urological Association
AUC area under the receiver operating characteristic curve
BAUS British Association of Urological Surgeons
Be-RALP Belgian Robot-Assisted Laparoscopic Prostatectomy registry
BMI body mass index
Bx biopsy
CAPRA Cancer of the Prostate Risk Assessment (score)
CENTRAL Cochrane Central Register of Controlled Trials
CHARMS Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies
CI confidence interval
C-index concordance index
ComBx combined (MRI-targeted plus systematic) biopsy
cT clinical T stage
CT computed tomography
DNA deoxyribonucleic acid
EAU European Association of Urology
EAU-YAU EAU Young Academic Urologists
EPE extraprostatic extension
ExoDx EPI ExoDx Prostate IntelliScore (urinary exosome assay)
FDA (US) Food and Drug Administration
GG (ISUP) Grade Group
GPS Genomic Prostate Score (Oncotype DX)
GRADE Grading of Recommendations, Assessment, Development and Evaluations
GS Gleason score
HR hazard ratio
IDC intraductal carcinoma
IQR interquartile range
ISUP International Society of Urological Pathology
MLM machine-learning model
mpMRI multiparametric magnetic resonance imaging
MRI magnetic resonance imaging
MRI-FIRST MRI-FIRST randomized trial
MUSIC Michigan Urological Surgery Improvement Collaborative
NCCN National Comprehensive Cancer Network
NCI (USA) National Cancer Institute
NLR neutrophil-to-lymphocyte ratio
NRG NRG Oncology (cooperative trials group)
OR odds ratio
PANDA Prostate cANcer graDe Assessment (challenge)
PCA3 prostate cancer antigen 3
PHI(D) Prostate Health Index (Density)
PI-RADS Prostate Imaging–Reporting and Data System
PICOTS Population, Index prognostic factor, Comparator, Outcome, Timing, Setting (review framework)
PNI perineural invasion
PRIMARY PRIMARY score (intraprostatic PSMA-PET assessment)
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PRISMA-P PRISMA for Protocols
PROBAST Prediction model Risk Of Bias Assessments Tool
PROMIS PROstate MR Imaging Study trial
PROSPERO International Prospective Register of Systematic Reviews
PSA/PSAD prostate-specific antigen/PSA density
PSMA prostate-specific membrane antigen
PSMA-PET PSMA positron emission tomography
pT pathological T stage
QUADAS-2 Quality Assessment of Diagnostic Accuracy Studies, version 2
QUIPS Quality In Prognosis Studies (tool)
RARP robot-assisted radical prostatectomy
RP radical prostatectomy
RTOG Radiation Therapy Oncology Group
SEER Surveillance, Epidemiology, and End Results (program)
SelectMDx urinary biomarker assay (proprietary name)
SMD standardized mean difference
SUVmax maximum standardized uptake value
SWiM Synthesis Without Meta-analysis (reporting guideline)
TRIPOD Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis
TRIPOD+AI TRIPOD+Artificial Intelligence extension
TRUS transrectal ultrasound
TRUS-Bx transrectal ultrasound-guided biopsy
UK United Kingdom
USA United States of America